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’ Background
Tremendous changes have occurred in enhanced recovery after
surgery (ERAS) since Danish surgeon Dr Kehlet published his landmark
article in 1997, emphasizing that major surgical procedures may lead to
signiﬁcant undesirable sequelae, including infection, pain, hemorrhage,
cardiopulmonary and thromboembolic complications, ileus, postoper-
ative nausea and vomiting, fatigue, and prolonged convalescence.1
In this regard, the surgical stress response and its subsequently increased
demands on organ function is the critical factor inﬂuencing postoperative
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morbidity and mortality.1 Signiﬁcant physiological derailment is mediated
by surgery and stress-induced endocrine/metabolic changes via activation
of multiple biological cascades, including hormones, arachidonic acid
metabolites, cytokines, complement, nitric oxide, and free oxygen radicals.2
ERAS adopts multidisciplinary approaches, multisystemic methods, and
multimodal interventions to decrease postoperative morbidity and mortal-
ity, to remarkably improve recovery, and to reduce overall costs.2,3 Over
the last 2 decades, ERAS programs have achieved accelerated recovery of
systemic functions and improved clinical outcomes.4,5 However, for
nonspeciﬁc reasons, cardiac surgery has lagged behind in establishing
similar ERAS protocols. Some studies have attempted to establish an
evidence-based ERAS protocol in cardiac surgery.6,7 The ERAS goals in
cardiac surgery include decreased complications, shortened intensive care
unit (ICU) and hospital stay, facilitation of functional recovery, and
improved perioperative patient experience and satisfaction (Fig. 1).
’ Perioperative Stress Responses
Physiological Alterations
The ﬁght-or-ﬂight responses activate the human autonomic nervous
system perioperatively. As Figure 2 illustrates, perioperative stress can
activate the autonomic nervous system and the hypothalamic-pituitary-
adrenal gland axis.8 Perioperative stress and surgical injury can lead
to an immunoinﬂammatory response. The initial response is
predominantly an excessive activation of innate immune pathways
manifested by a pronounced systemic inﬂammatory response and
potential organ injury. Later, patients will have a persistent depression
in adaptive immunity, greater suseptibility to nosocomial infections,9 and
typically depression in T-cell responses. Recent studies indicate that
innate immune receptors detect tissue injury, such as Toll-like receptor
Figure 1. Overall goals for ERAS. ERAS indicates enhanced recovery after surgery; ICU,
intensive care unit.
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4, and trigger the respective response.8,10 Inﬂammatory cytokines are
formed and released in surgical patients. These cytokines include tumor
necrotizing factor, multiple interleukins, etc. Cardiac surgery leads to an
increased level of inﬂammatory cytokines, and statins may have some
beneﬁcial effects; rosuvastatin was found to attenuate these cytokine
alterations.11
Postoperative patients admitted to ICU are at increased risk of
developing gastrointestinal ischemia and potential bacterial translocation,
which may cause bacteremia, endotoxemia, and even sepsis, multiple
organ failure, and ultimately death. The duration of cardiopulmonary
bypass (CPB) is associated with increased intestinal permeability and
increased risk of bacterial translocation.12
Perioperative stress can induce an upregulation of inducible nitric
oxide synthase in organs such as the liver, lung, and spleen, and in the
Figure 2. Perioperative stress induces pathophysiological changes.8
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vascular system.13,14 Statins were found to have cardioprotective and
anti-inﬂammatory properties perioperatively, likely by attenuation of the
systemic inﬂammatory response and inhibition of nitric oxide metabo-
lism. In this regard, pravastatin preloading has been demonstrated to
signiﬁcantly and dose relatedly result in an intense reduction in systemic
inﬂammatory response with signiﬁcant decrease in nitric oxide release
and inducible nitric oxide synthase expression13 (Fig. 2).
The multiple systemic effects of perioperative stress lead to
potentially harmful consequences, as shown in Table 1.
’ Preoperative Patient Evaluation and Preparation
Preoperative Patient Preparations
All elective patients should be evaluated preoperatively.15 The
preanesthetic evaluation should include cardiopulmonary function, liver
and renal function, metabolic status, and other potential comorbidities.
Surgical risks should be stratiﬁed by using the standard ACS Risk
Calculator. If risk of major adverse cardiac event exceeds 1%, the patient
should be referred for further cardiac testing/clearance.16 Methicillin-
resistant Staphylococcus aureus should also be screened.17 The patient’s
physical condition needs to be optimized preoperatively as well, including
preoperative nutritional optimization, which must comprise the following:
(1) daily fruit and vegetables; (2) starchy foods (rice, bread, pasta, and
potatoes) at each mealtime; (3) protein-rich foods such as lean meat, ﬁsh,
eggs, beans, etc.; and (4) limited intake of foods high in fat, sugar, and
salt.18,19 The patient’s family should be equally well informed as to what is
expected for the whole perioperative course and how they should
cooperate with health care providers to facilitate postoperative recovery.
Other preoperative preparation includes:
 Incentive spirometry training: this will help the patient become
familiar with the use of incentive spirometry. Patients will do better if
incentive spirometry is needed to prevent or to manage postoperative
pneumonia.20
 Use of antiseptic soap before surgery.
Table 1. Neurohumoral Alterations as Responses to Perioperative Stress
Hypoxemia
↑↑Myocardial oxygen demand→myocardial ischemia
Vasoconstriction may hinder wound healing and vascular anastomosis
Stress-induced exhaustion of energy and loss of muscle mass lead to weakness
(DVT, pneumonia)
↑↑Risk of infection
Hypercoagulatory status→thromboembolic event
Sodium and water retention
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 Oral administration of statins.
 Preoperative physical preparedness.
∘ Patients should exercise for at least 15 minutes daily 2 weeks
preoperatively.
∘ Patients should practice getting in and out of bed, standing up,
and sitting down in a chair, and general everyday living activities
within the home.18,19
Preoperative Management on the Day of Surgery
Avoidance of long fasting has been documented to be beneﬁcial to
surgical patients.18 Most ERAS® protocols suggest clear liquids up to
2 hours before surgery.15 Most protocols suggest a carbohydrate-
containing drink 1 hour before arrival at the hospital.15 Surgical stress
in the presence of fasting worsens the catabolic state, which may cause
insulin resistance and delay recovery. Studies have shown that
preoperative administration of oral carbohydrate liquid is safe and may
have a favorable inﬂuence on perioperative variables of clinical
outcome.21
The patient should have a dose of anxiolytics to minimize anxiety and
decrease preoperative stress. However, benzodiazepines should be avoided
and opioids minimized for patients who are over 70 years of age.4
A study of 240 high-risk cardiac surgery patients with Cleveland Clinic
Foundation score 6 or higher found that remote ischemic preconditioning
was associated with signiﬁcant absolute risk reduction, reduced incidence
of 3-month composite endpoint major adverse kidney events and
enhanced renal recovery in patients with acute kidney injury.22
’ Intraoperative Management
Prophylaxis of Infection
Antibiotic(s) with appropriate bacterial coverage should be adminis-
tered 30 minutes before surgical incision (2 h for vancomycin and
ﬂuoroquinolones).23 Some hospitals have strictly followed Surgical Care
Improvement Project guidelines and have demonstrated decreased
surgical-site infections by roughly 25% from 2006 to 2010. Antibiotics
may be given orally or IV, depending on the procedure.2,24 It is
abundantly clear that antibiotics should be given before central venous
catheterization, which is typically needed for cardiovascular surgical
procedures.
Anxiolytic and Amnestic Agents
The current trend is to minimize the use of benzodiazepines and to
avoid benzodiazepines for patients who are over 70 years of age.4
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However, benzodiazepines do provide an amnestic effect, which
is important in cardiac surgical procedures, especially when a patient is
hypotensive, necessitating reduction in anesthetic delivery.
Opioid Use and Sympatholytic Therapy
Opioid use in cardiac surgery has been steadily declining over the
last 2 decades; however, opioids block perioperative stress response.
Epidural and intrathecal administration of opioids have been shown to
help attenuate perioperative stress responses.25
Standardized Preemptive Multimodal Analgesia
The multimodal approach should include ≥2 of the following
categories of medications: opioids, nonsteroidal anti-inﬂammatory drugs,
acetaminophen, and gabapentin.15 Analgesic agents are to be given
preoperatively and in the early stages during surgical procedures. Smaller
doses should be considered to avoid over-sedated patients after surgery.
If applicable, thoracic epidural analgesia should be considered for
cardiac surgery, although there is an increased risk of complications due
to systemic anticoagulation. Sen and colleagues prospectively studied 60
patients scheduled for coronary artery bypass grafts (CABG) surgery.
They discovered thoracic epidural analgesia with fentanyl and bupiva-
caine provided optimal postoperative analgesia at rest and during
coughing in patients following coronary bypass grafting surgery.25
Negro Neto and colleagues studied the intrathecal administration of
sufentanil for coronary artery bypass grafts (CABG) patients, measuring
patients’ hemodynamic variables, interleukin-6, blood levels of cardiac
troponin I, tumor necrosis factor, and B-type natriuretic peptide during
and after surgery. The results demonstrated that the sufentanil group
required remarkably less dopamine support than the control group and
less increases in remifentanil doses.26
Anti-inflammatory Therapy
Systemic inﬂammation has been well recognized in cardiac surgery.
Such inﬂammation is induced by tissue injury, contact with the artiﬁcial
surface of the bypass circuit, hypothermia and reduction of pulmonary
blood ﬂow during surgery, as well as perioperative stress. Steroids are
recommended by some cardiac surgery programs, although there is no
consensus on whether steroids should be routinely administered to all
cardiac surgery patients.27 High spinal anesthesia added to general
anesthesia can potentially attenuate systemic inﬂammatory responses.28
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Fluid Management and Blood Transfusion
Cardiac patients usually have invasive monitors easily allowing for
monitoring of volume status. Central venous pressure, stroke volume
variations, and transesophageal echocardiography can be used to
directly estimate volume status. Avoidance of ﬂuid overload is advised,
especially in patients undergoing CPB, as the CPB circuit has about 2 L
of priming ﬂuid. Patients undergoing cardiac surgery are more likely to
receive blood transfusion because of the high risk of blood loss.
The blood transfusion guidelines are not universally accepted, and a
great variability exists in the use of blood products between countries,
institutions, and practitioners. The hemoglobin level to initiate trans-
fusion has been steadily declining over the last decades.29 Transfusion-
associated acute lung injury has been increasingly recognized as a
complication of transfusion. Hospitals need to develop protocols to avoid
or minimize blood transfusion, which can include reversal of anti-
coagulant, acute normovolemic hemodilution, antiﬁbrinolytic agents,
and other hemostatic pharmacological agents.29,30
Vasoactive Medications
There are tremendous variations in selecting vasoactive medications
intraoperatively at different institutions. Discrepancies exist in several
areas. Some physicians use epinephrine and dobutamine as a combina-
tion to treat patients with low cardiac output and hypotension. There are
studies demonstrating that relatively weak sympathomimetic agents
(dobutamine) can potentially antagonize potent sympathomimetic agents
(epinephrine). If synergistic inotropic and/or vasoconstricting effects are
needed, they may not be a favorable combination.31 Some surgeons
request nitroglycerin for spasm prevention of the radial or mammary
artery conduit graft, whereas others use nicardipine. We believe
nicardipine is a better choice. Nitroglycerin is known as a coronary
artery dilator; however, radial and mammary artery grafts are
anatomically and physiologically arterial vessels. They likely would
respond to a direct arterial dilator (eg, nicardipine) better than the
venous dilator nitroglycerin.32,33
Long-acting β-adrenergic receptor antagonists (atenolol, labetalol)
are often administered during cardiac surgical procedures. β1-adrener-
gic receptors are critical in maintaining cardiac rhythm and myocardial
contractility; if blocked by selective β1-adrenergic receptor antagonists,
patients may develop bradycardia and/or hypotension, and sympatho-
mimetic agents such as epinephrine, norepinephrine, or dobutamine
may not be able to activate/stimulate β1-adrenergic receptors. We suggest
only using selective short-acting β1-adrenergic receptor antagonists
intraoperatively (eg, esmolol). Catecholamine administration has been
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associated with adverse clinical outcomes; hence, epinephrine should be
cautiously used perioperatively.34–36
Blood Glucose Level
High blood glucose levels have been associated with elevated
morbidity and mortality in surgical patients.37 Many studies with regard
to hyperglycemia in cardiac surgery have been published; however,
those studies have used wide variations in the deﬁnitions of hyper-
glycemia, methodology, timing, and dosing of insulin administration.
More importantly, hypoglycemia can cause signiﬁcant problems. After
the Leuven study described better outcomes with tighter glucose
parameters,37 tight glycemic control became popular. However, several
large-scale multicenter studies have led practice guidelines to be
modiﬁed recently, favoring conventional, less-tight control. It appears
beneﬁcial that diabetic patients can be managed with blood glucose
allowed up to 180mg/dL and nondiabetic patients at <140mg/dL.37
Invasive Monitors
The overall trend is a decrease in invasive monitoring and increased
use of less-invasive or noninvasive monitoring. Transesophageal echo-
cardiography is increasingly used as an intraoperative monitor in cardiac
surgery and can provide almost all parameters that a Swan-Ganz catheter
can provide, except mixed venous oxygen saturation. Less complicated
cardiac surgery patients only need a central venous catheter,38 which is
unlikely to be replaced by other volume monitors, because it functions as
a large-bore intravenous access as well.
Intraoperative Normothermia
Surgical patients are prone to lose heat intraoperatively. General
anesthesia changes the regulatory set-point in the brain for defense
against cold exposure, rendering the patient poikilothermic. Hypo-
thermia will pose signiﬁcant stress to surgical patients. Therefore,
temperature in the operative rooms should be maintained between 20°
C and 25°C, and many other strategies will be utilized to keep surgical
patients normothermic.2
Surgical Hemostasis
Thorough surgical hemostasis intraoperatively is critical to the
success of the surgery and the recovery of the patient. Many “bring
back” surgical cases are due to rebleeding, which causes signiﬁcant
postoperative morbidity and mortality.
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Minimally Invasive Approaches
Minimally invasive techniques have been well documented to
facilitate postoperative recovery in many surgical subspecialties.39
Robotic techniques allow surgeons to perform cardiac surgery endo-
scopically rather than through sternotomy. This approach facilitates
multiple cardiac procedures involving the mitral valve, atrial septal
defects, and coronary artery system. In Europe, robotic coronary surgery
has been performed safely and effectively in the last 15 years with very
few perioperative complications. Robotic mitral valve surgery has also
been increasingly utilized in the last 5 to 6 years.40 Integration of robotic
endoscopic cardiac surgery into ERAS is not only feasible and safe but
also potentially synergistic with respect to postoperative recovery. One
retrospective study showed signiﬁcantly lower blood transfusion, shorter
ICU duration by 24 hours, and a 4-day decrease in hospital stay in the
robotic endoscopic CABG group.39
’ Postoperative Management
Ventilation Management
With currently available techniques, the majority of cardiac surgical
patients will need postoperative mechanical ventilation. Prolonged intuba-
tion may cause ventilator-associated pneumonia (VAP) as a complication.
The incidence of VAP after cardiac surgery is estimated to be as high as 30%,
and S. aureus and Pseudomonas aeruginosa are the most commonly involved
microorganisms.41 Prevention of VAP may need to start with a protective
ventilation mode intraoperatively.42 Ventilatory protective settings include
low tidal volume, and potentially positive end-expiratory pressure and
recruitment maneuvers. Postoperatively, low tidal volume and tight control
of driving pressure should be applied. Ventilation driving pressure should
be maintained as low as possible.26 Patients should be extubated as soon as
they reach extubation criteria and have no other major medical issues.43
Physiotherapy, early mobilization, and respiratory monitoring may play an
important role in preventing postoperative pulmonary complications and
enhance recovery.44
Postoperative Sedation
As most cardiac surgery patients will need mechanical ventilation
postoperatively in the ICU, sedation of these patients will be paramount.
Postoperative sedation for patients after cardiac surgery in the ICU
needs to be tailored to facilitate the patient’s anticipated emergence, to
reduce postoperative discomfort and anxiety, and to accommodate
frequent suctioning and physiotherapy. Benzodiazepines and propofol
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are commonly utilized in the ICU to sedate ventilated patients, with
dexmedetomidine being increasingly used as well.45
Pain Management
Multimodal analgesia is highly recommended by many expert
consensus statements and guidelines.15 Inadequate control of post-
operative pain may lead to prolonged immobilization, insufﬁcient lung
expansion and respiratory dysfunction, and patient’s inability to cough
related to median sternotomy. Hence, the duration of mechanical
ventilation, length of ICU stay, and length of hospital stay will also be
signiﬁcantly increased. Thus, adequate analgesia after cardiac surgery is
critically important in the recovery of patients from cardiac surgery.46
Opioids are the choice of potent analgesic agents. However long-acting
opioids should be minimized in postoperative analgesia unless the patient is
expected to be mechanically ventilated for an extended period. Non-
steroidal anti-inﬂammary drugs are an excellent adjunct for postoperative
analgesia, but their potential renal, gastrointestinal, and coagulative
complications and their analgesic potency are barriers for their sole or
routine use in cardiac surgical patients.47
The major source of pain in cardiac surgery patients is from the
median sternotomy and the mediastinal drainage tube sites. The sternum is
innervated by the anterior and posterior branches of intercostal nerves,
which can be blocked by parasternal local anesthetic inﬁltration. This block
is simple and easy to perform and is not contraindicated even in
anticoagulated patients.48 Neuraxial block has also been recommended4
as a sole anesthetic for noncardiac surgical procedures or as an adjunct
analgesic measure for noncardiac and cardiac surgical procedures.
Early Mobilization Postoperatively With Physiotherapy
Assistance
Immobilized critically ill patients are at risk to develop pneumonia,
neuromyopathy, sepsis, and multiorgan failure.49 Early mobility inter-
ventions can have enormous beneﬁts: improved range of motion,
decreased incidence of pneumonia, better muscle strength and func-
tional status, and decreased length of ICU and hospital stay. Early
mobilization is also possible in mechanically ventilated patients.49 Most
ERAS protocols recommend early mobilization.15,50
Facilitation of Gastrointestinal Function Recovery
Gastrointestinal function recovery can be enhanced by adopting
early oral nutrition, chewing gum use, and pharmacologically promoting
gastrointestinal motility. Alvimopam, a selective μ-opioid receptor
blocker, can be administered after starting oral intake until return of
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bowel function. Early oral nutrition can promote intestinal peristalsis,
and improve nutrition and ﬂuid intake, thus decreasing intravenous
ﬂuid requirement and potentially decrease bacterial translocation, thus
lowering the risk of endotoxemia and sepsis.15
Early Removal of Nasogastric Tube, Foley Catheter, and
Drainage Tube(s)
All indwelling catheters and tubes will potentially increase the incidence
of infection and sepsis. Hence, most ERAS protocols and expert consensus
recommend minimizing the use of indwelling catheters and tubes. If
medically needed, those inserted catheters and tubes should be removed as
soon as medical conditions allow.15 For patients needing indwelling central
venous catheterization, the catheter should be removed and replaced in
no >1 week, or whenever the patient’s body temperature escalates.
Fluid Management
Fluid management based on ERAS protocol should be viewed as a
continuum throughout the preoperative, intraoperative, and postoper-
ative phases. Any phase with suboptimal care can potentially compromise
the overall results. Excessive salt should generally be avoided because
these patients usually do not have the same capability to excrete sodium
and chloride postoperatively. The aim should be to provide low-sodium
and low-volume ﬂuids to postoperative patients. Goal-targeted therapy
should be utilized if available, especially in high-risk patients.22,51 After
oral ﬂuid intake starts, intravenous ﬂuid administration should be
reduced or discontinued. An average patient without existing ﬂuid
deﬁcits or ongoing losses should be encouraged to orally intake 1.75 L/d.
Without other medical concerns or in the state of normovolemia,
permissive oliguria should be tolerated.51
’ ERAS® Variables in Cardiac Surgery4,52
The following variables are useful metrics for the enhanced recovery
pathway to keep track of clinical outcomes, measure compliance with the
protocol, and to conduct research:
 Incidence and severity of postoperative complications
 Time to extubation in the ICU
 Time to oral intake and recovery of gastrointestinal function
 Time to early mobilization
 Incidence of surgical complications
 ICU stay
 Total hospital stay
 Patient satisfaction
 Total hospital costs
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’ Current ERAS Studies in Cardiac Surgery and
Outcomes
A widely accepted ERAS protocol for cardiac surgery will take some
efforts. Perkins and colleagues reported implementing the ERAS
program in England beginning in 2009. Their patients have been
successfully admitted for cardiac surgery on the day of surgery. Their
ERAS program is supported by multidisciplinary preadmission clinics 1
week preoperatively for all cardiothoracic patients and adopted for all
ﬁrst-time CABG patients. They started ERAS with gastrointestinal
surgery in 2009 and cardiac surgery in 2013.53 Cardiac surgery without
CPB can also be included in the ERAS cardiac surgery program. Fleming
and colleagues adopted a protocol including preoperatively detailed
patient evaluation, avoiding prolonged preoperative fasting, preoper-
ative carbohydrate intake, multimodal analgesia avoiding long-acting
opioids, prophylaxis of postoperative nausea and vomiting, early enteral
nutrition, and early mobilization. They found that ERAS produced
signiﬁcantly lower postoperative complications (acute kidney injury,
atrial ﬁbrillation, infections, respiratory failure, acute myocardial
infarction, and death). They believe that ERAS in cardiac surgery is
feasible and may improve postoperative morbidity and mortality.6
Kenny and colleagues also reported favorable results in relatively
elderly patients who underwent cardiac surgery, with the mean age
being 67.5 in the CABG group and 72.9 in the aortic valve replacement
group. Their ICU stay ranged from 0.7 to 5.1 days (median, 0.9 d) for
the CABG group and 0.7 to 18.8 days (median, 0.9 d) for the aortic valve
replacement group. Hospital stay ranged from 3 to 8 days (median, 5 d)
for CABG and 5 to 35 days (median, 9 d) for aortic valve replacement.
These results represented a 17% reduction in hospital stay for CABG
patients.54 As multimodal perioperative pain therapy signiﬁcantly
contributed to patient care,55 ERAS has the potential to contribute to
perioperative care in cardiac surgery.
’ Summary
Cardiac ERAS represents a common sense appreciation for the
mediation or modulation of the stress response to surgery, anesthetic
management to facilitate recovery, and a heavy emphasis on practical
strategies initiated before surgery to enhance recovery postoperatively.
This review builds upon ERAS investigations over the past 20 years and
represents the best practice strategies for cardiac surgical patients. These
strategies require a buy-in from all stakeholders, including surgeons,
nurses, and administration. Forming a Cardiac ERAS group at each
hospital facility will help build team consensus and gain support for its
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implementation, with anesthesia providers playing a critical role in this
process. At present, reimbursement is typically bundled, and this means
that improved recovery and ultimate discharge home without return to
the hospital is ﬁnancially beneﬁcial to the facility and directly improves
outcomes of patients.
The authors declare that they have nothing to disclose.
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